Antimony-containing Substances Group
Information sheet
These substances were identified for action under the Chemicals Management Plan (CMP).
| Substance group | CAS RN | Common name | DSL name | Public comments received on the draft screening assessment | Final screening assessment | Conclusion on section 64 criteria | Follow-up activities |
|---|---|---|---|---|---|---|---|
| Antimony-containing Substance Group | 1314-60-9 | Antimony pentoxide | Antimony oxide (Sb2O5) | HTML | HTML | Does not meet | None planned at this time |
| 1327-33-9a | Antimony oxide | Antimony oxide | |||||
| 1345-04-6 | Antimony sulfide | Antimony sulfide (Sb2S3) | |||||
| 10025-91-9 | Antimony trichloride | Stibine, trichloro- | |||||
| 15432-85-6 | Sodium antimonate | Antimonate (SbO31-), sodium | |||||
| 15874-48-3 | NA | Phosphorodithioic acid, O,O-dipropyl ester, antimony(3+) salt | |||||
| 15890-25-2 | Antimony diamyldithiocarbamate | Antimony, tris(dipentylcarbamodithioato-S,S')-, (OC-6-11)- | |||||
| 15991-76-1 | NA | Antimony, tris[bis(2-ethylhexyl)carbamodithioato-S,S']-, (OC-6-11)- | |||||
| 28300-74-5 | Antimony potassium tartrate (APT) | Antimonate(2-), bis[µ-[2,3-di(hydroxy-κO)butanedioato(4-)-κO1:κO4]]di-, dipotassium, trihydrate, stereoisomer | |||||
| 29638-69-5 | Potassium antimonate | Antimonate (Sb2O74-), tetrapotassium | |||||
| 33908-66-6 | Sodium hexahydroxoantimonate | Antimonate (Sb(OH)61-), sodium, (OC-6-11)- |
| Date | Activity |
|---|---|
| July 11, 2020 | Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol 154, No. 28. |
| September 15, 2018 | Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 37. |